At the moment the team is growing. With this team, we aim to build the blood circulation system. One of the main focus areas of the initial team will be the recruiting of scientists and engineers. Some of these have already been identified.
We are also in discussions with a Chief Technology officer, to lead the development of the engineering aspects of and technical systems we aim to produce.
We are looking for technical experts who are ready to dive into a wholly new area of practical development. We will need people with a biotechnology background, especially with knowledge of hematology and endocrinology. We will also need people with a technical mindset like clinical technologists.
Robert ten Hoor, CEO
Studied computer science at Delft University of Technology. Lived and worked in many countries for about 10 years. Most of the time in London where he worked as business strategy consultant. He was involved in many start-ups, investor roadshows etc. Now back in the Netherlands for about 15 years. He is entrepreneur, also involved in some smaller start-ups like EfficientFashion and SchienenZeppelin.
Wing Yee Hung (Karen), Chief Scientist (biotechnology)
Karen holds a PhD in Biochemistry from the university Duisburg. She is a food and animal rights enthusiast, a weekday vegetarian and she blogs about clean meat at futurefoodster.com
Marco Stijnen, R&D Director
Marco received his PhD in 2004 on flow phenomena around heart valve prostheses at the Eindhoven University of Technology. Subsequently he co-founded HemoLab and LifeTec Group, focusing on contract research projects for the biomedical industries, clinical institutes and academia. Marco will design and lead the biotechnology of the blood circulation.
Wim van den Broek, CFO
Wim has over 20 year of experience as CFO. He has worked as controller, director of finance and CFO in high-tech start-up environments. Wim will be in charge of the capital funding rounds.